2021
DOI: 10.1016/j.toxrep.2021.06.014
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of the protective effect of acetazolamide and SLC-0111 on carbon tetrachloride-induced toxicity in fruit fly

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 42 publications
0
6
0
Order By: Relevance
“…The laboratory conditions to maintain the colony were 25°C–30°C and 55 ± 5% relative humidity with some minor modifications. [ 35–37 ]…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The laboratory conditions to maintain the colony were 25°C–30°C and 55 ± 5% relative humidity with some minor modifications. [ 35–37 ]…”
Section: Methodsmentioning
confidence: 99%
“…The laboratory conditions to maintain the colony were 25°C-30°C and 55 ± 5% relative humidity with some minor modifications. [35][36][37] In the study, seven serial dilutions were prepared from each of the AH1-12 chemical compounds from 1/2 to 1/128. All chemical compounds were dissolved in DMSO and diluted with the same solution.…”
Section: Larvicidal Activitymentioning
confidence: 99%
“…L. sericata was reared in a 12 m 2 room under laboratory conditions of 25°C-30°C and 50 ± 5% relative humidity (RH) in a particular light source. [32][33][34][35][36] Adults were fed on sucrose and water, but larvae were reared on chicken liver-agar medium recommended by Mumcuoğlu, [33] Uslu, [34] Aydın & Uslu, [35] and Uslu et al [36]…”
Section: Insect Culturementioning
confidence: 99%
“…[22][23][24] The ureido benzenesulfonamide SLC-0111 (Figure 1), as the first selective CA IX/XII inhibitor, is currently in Phase I/II clinical trials for the treatment of advanced, metastatic hypoxic tumors. [25][26][27] Therefore, the design of high affinity, isozymeselective inhibitors devoid of causing side effects due to off-target CA modulation would be a fruitful and effective strategy for the development of potent therapeutic agents. [2] Literature survey highlights that 1,2,3-triazole-based heterocyclic scaffolds possess a wide array of pharmacological activities including antimicrobial, [28] antiproliferative, [29] antitubercular, [30] anti-HIV, [31] antibacterial, [32] anticancer, [33] and so on.…”
Section: Introductionmentioning
confidence: 99%
“…[ 22–24 ] The ureido benzenesulfonamide SLC‐0111 (Figure 1), as the first selective CA IX/XII inhibitor, is currently in Phase I/II clinical trials for the treatment of advanced, metastatic hypoxic tumors. [ 25–27 ] Therefore, the design of high affinity, isozyme‐selective inhibitors devoid of causing side effects due to off‐target CA modulation would be a fruitful and effective strategy for the development of potent therapeutic agents. [ 2 ]…”
Section: Introductionmentioning
confidence: 99%